Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlyin...
Leadership
Howard W. Robin
CEO, President & Director
Jonathan Zalevsky Ph.D.
Senior VP and Chief Research & Development Officer
Linda M. Rubinstein M.A.
CFO and Principal Financial & Accounting Officer
Jason Barnard
Chief Accounting Officer
Elizabeth Zhang
VP of Legal, Corporate Counsel & Secretary
Robert Bacci
Chief People Officer and Head of Quality & Facilities
Jennifer Ruddock
Chief Business Officer
Mary Tagliaferri L.Ac., M.D.
Chief Medical Officer
Ken Franke Ph.D.
Senior Vice President of Biologics Process Development & Manufacturing
Charleen Jue
Senior Vice President of Clinical Development Operations
